Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
LPI (LP Information)' newest research report, the “Next-Generation Drug-Eluting Stent Industry Forecast” looks at past sales and reviews total world Next-Generation Drug-Eluting Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Next-Generation Drug-Eluting Stent sales for 2023 through 2029. With Next-Generation Drug-Eluting Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Drug-Eluting Stent industry.
This Insight Report provides a comprehensive analysis of the global Next-Generation Drug-Eluting Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Drug-Eluting Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Next-Generation Drug-Eluting Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Drug-Eluting Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Drug-Eluting Stent.
The global Next-Generation Drug-Eluting Stent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Drug-Eluting Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Cobalt Chromium
Stainless Steel
Others
Segmentation by application
Hospitals
Clinics
Ambulatory Surgical Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Next-Generation Drug-Eluting Stent market?
What factors are driving Next-Generation Drug-Eluting Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Next-Generation Drug-Eluting Stent market opportunities vary by end market size?
How does Next-Generation Drug-Eluting Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Next-Generation Drug-Eluting Stent by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Next-Generation Drug-Eluting Stent by Country/Region, 2018, 2022 & 2029 2.2 Next-Generation Drug-Eluting Stent Segment by Type 2.2.1 Cobalt Chromium 2.2.2 Stainless Steel 2.2.3 Others 2.3 Next-Generation Drug-Eluting Stent Sales by Type 2.3.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2018-2023) 2.3.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Type (2018-2023) 2.3.3 Global Next-Generation Drug-Eluting Stent Sale Price by Type (2018-2023) 2.4 Next-Generation Drug-Eluting Stent Segment by Application 2.4.1 Hospitals 2.4.2 Clinics 2.4.3 Ambulatory Surgical Centers 2.5 Next-Generation Drug-Eluting Stent Sales by Application 2.5.1 Global Next-Generation Drug-Eluting Stent Sale Market Share by Application (2018-2023) 2.5.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Application (2018-2023) 2.5.3 Global Next-Generation Drug-Eluting Stent Sale Price by Application (2018-2023) 3 Global Next-Generation Drug-Eluting Stent by Company 3.1 Global Next-Generation Drug-Eluting Stent Breakdown Data by Company 3.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Company (2018-2023) 3.1.2 Global Next-Generation Drug-Eluting Stent Sales Market Share by Company (2018-2023) 3.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Company (2018-2023) 3.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Company (2018-2023) 3.2.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Company (2018-2023) 3.3 Global Next-Generation Drug-Eluting Stent Sale Price by Company 3.4 Key Manufacturers Next-Generation Drug-Eluting Stent Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Next-Generation Drug-Eluting Stent Product Location Distribution 3.4.2 Players Next-Generation Drug-Eluting Stent Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Next-Generation Drug-Eluting Stent by Geographic Region 4.1 World Historic Next-Generation Drug-Eluting Stent Market Size by Geographic Region (2018-2023) 4.1.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Next-Generation Drug-Eluting Stent Market Size by Country/Region (2018-2023) 4.2.1 Global Next-Generation Drug-Eluting Stent Annual Sales by Country/Region (2018-2023) 4.2.2 Global Next-Generation Drug-Eluting Stent Annual Revenue by Country/Region (2018-2023) 4.3 Americas Next-Generation Drug-Eluting Stent Sales Growth 4.4 APAC Next-Generation Drug-Eluting Stent Sales Growth 4.5 Europe Next-Generation Drug-Eluting Stent Sales Growth 4.6 Middle East & Africa Next-Generation Drug-Eluting Stent Sales Growth 5 Americas 5.1 Americas Next-Generation Drug-Eluting Stent Sales by Country 5.1.1 Americas Next-Generation Drug-Eluting Stent Sales by Country (2018-2023) 5.1.2 Americas Next-Generation Drug-Eluting Stent Revenue by Country (2018-2023) 5.2 Americas Next-Generation Drug-Eluting Stent Sales by Type 5.3 Americas Next-Generation Drug-Eluting Stent Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Next-Generation Drug-Eluting Stent Sales by Region 6.1.1 APAC Next-Generation Drug-Eluting Stent Sales by Region (2018-2023) 6.1.2 APAC Next-Generation Drug-Eluting Stent Revenue by Region (2018-2023) 6.2 APAC Next-Generation Drug-Eluting Stent Sales by Type 6.3 APAC Next-Generation Drug-Eluting Stent Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Next-Generation Drug-Eluting Stent by Country 7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Country (2018-2023) 7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Country (2018-2023) 7.2 Europe Next-Generation Drug-Eluting Stent Sales by Type 7.3 Europe Next-Generation Drug-Eluting Stent Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Next-Generation Drug-Eluting Stent by Country 8.1.1 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2018-2023) 8.1.2 Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2018-2023) 8.2 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Type 8.3 Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Next-Generation Drug-Eluting Stent 10.3 Manufacturing Process Analysis of Next-Generation Drug-Eluting Stent 10.4 Industry Chain Structure of Next-Generation Drug-Eluting Stent 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Next-Generation Drug-Eluting Stent Distributors 11.3 Next-Generation Drug-Eluting Stent Customer 12 World Forecast Review for Next-Generation Drug-Eluting Stent by Geographic Region 12.1 Global Next-Generation Drug-Eluting Stent Market Size Forecast by Region 12.1.1 Global Next-Generation Drug-Eluting Stent Forecast by Region (2024-2029) 12.1.2 Global Next-Generation Drug-Eluting Stent Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Next-Generation Drug-Eluting Stent Forecast by Type 12.7 Global Next-Generation Drug-Eluting Stent Forecast by Application 13 Key Players Analysis 13.1 Abbott 13.1.1 Abbott Company Information 13.1.2 Abbott Next-Generation Drug-Eluting Stent Product Portfolios and Specifications 13.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Abbott Main Business Overview 13.1.5 Abbott Latest Developments 13.2 Biosensors International 13.2.1 Biosensors International Company Information 13.2.2 Biosensors International Next-Generation Drug-Eluting Stent Product Portfolios and Specifications 13.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Biosensors International Main Business Overview 13.2.5 Biosensors International Latest Developments 13.3 Medtronic 13.3.1 Medtronic Company Information 13.3.2 Medtronic Next-Generation Drug-Eluting Stent Product Portfolios and Specifications 13.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Medtronic Main Business Overview 13.3.5 Medtronic Latest Developments 13.4 Sorin Group 13.4.1 Sorin Group Company Information 13.4.2 Sorin Group Next-Generation Drug-Eluting Stent Product Portfolios and Specifications 13.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Sorin Group Main Business Overview 13.4.5 Sorin Group Latest Developments 13.5 SMT 13.5.1 SMT Company Information 13.5.2 SMT Next-Generation Drug-Eluting Stent Product Portfolios and Specifications 13.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 SMT Main Business Overview 13.5.5 SMT Latest Developments 13.6 Terumo 13.6.1 Terumo Company Information 13.6.2 Terumo Next-Generation Drug-Eluting Stent Product Portfolios and Specifications 13.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Terumo Main Business Overview 13.6.5 Terumo Latest Developments 14 Research Findings and Conclusion